About

An experienced team in immunology and drug development.

Inicure AB was founded in 2024 in Gothenburg, Sweden. We develop patent-protected compounds supported by peer-reviewed science.

Peter Olofsson-Sahl

CEO

Preclinical drug development and international project management. Founder of several innovative research companies.

Chair Board of Directors

Business development and investment management. Experienced life science start-up executive and Board professional.

CSO

Professor in Microbiology, focused on immunology and infections including targeting of immunological mechanisms.

Researcher — Product Development

Immunology and infection biology combined with bio-engineering, method development and instrumentation.

Company